Cargando…
In this issue: Volume 113, Issue 2, February 2022
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819340/ http://dx.doi.org/10.1111/cas.14946 |
| _version_ | 1784646040869142528 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8819340 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88193402022-02-11 In this issue: Volume 113, Issue 2, February 2022 Cancer Sci In This Issue John Wiley and Sons Inc. 2022-02-06 2022-02 /pmc/articles/PMC8819340/ http://dx.doi.org/10.1111/cas.14946 Text en © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | In This Issue In this issue: Volume 113, Issue 2, February 2022 |
| title | In this issue: Volume 113, Issue 2, February 2022 |
| title_full | In this issue: Volume 113, Issue 2, February 2022 |
| title_fullStr | In this issue: Volume 113, Issue 2, February 2022 |
| title_full_unstemmed | In this issue: Volume 113, Issue 2, February 2022 |
| title_short | In this issue: Volume 113, Issue 2, February 2022 |
| title_sort | in this issue: volume 113, issue 2, february 2022 |
| topic | In This Issue |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819340/ http://dx.doi.org/10.1111/cas.14946 |